Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors of H. pylori Infection and Eradication Failure in Xi'an
NCT05226819Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Feb 2022
- Primary completion
- Sep 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Open-label trial of rabeprazole, amoxicillin, clarithromycin and colloidal bismuth tartrate in Helicobacter pylori infection (3 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Infection rate at 1 year, The Affecting factors of Helicobacter pylori infection at 1 year and 2 more. Status: unknown.
02
Drugs
rabeprazoleamoxicillinclarithromycincolloidal bismuth tartrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05226819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05226819.